HOUSE DOCKET, NO. 2137        FILED ON: 1/20/2023

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 3574

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Nicholas A. Boldyga

_________________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:

The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act concerning the use of a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA).

_______________

PETITION OF:

 

Name:

District/Address:

Date Added:

Nicholas A. Boldyga

3rd Hampden

1/19/2023


HOUSE DOCKET, NO. 2137        FILED ON: 1/20/2023

HOUSE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 3574

By Representative Boldyga of Southwick, a petition (accompanied by bill, House, No. 3574) of Nicholas A. Boldyga relative to the use of a certain prescription medication used in psychotherapy and the treatment of post-traumatic stress disorder.  Elder Affairs.

 

The Commonwealth of Massachusetts

 

_______________

In the One Hundred and Ninety-Third General Court
(2023-2024)

_______________

 

An Act concerning the use of a prescription medicine that contains 3,4-methylenedioxymethamphetamine (MDMA).

 

Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

SECTION 1. Section 7 of chapter 94C of the General Laws, as appearing in the 2020 Official Edition, is hereby amended by adding the following subsection:-

(j) Any person or entity registered to prescribe, manufacture, distribute, dispense or provide services related to 3,4-methylenedioxymethamphetamine (MDMA) shall not charge more than $5,000 per MDMA treatment service unit. For the purposes of this subsection, “MDMA treatment service unit” shall mean any prescribed and controlled administration of MDMA in any 7-day consecutive period including therapy and related counseling.

SECTION 2. Paragraph (a) of Class B of section 31 of chapter 94C of the General Laws, as so appearing, is hereby amended by striking out clause (8).

SECTION 3. Section 2 of this act shall take effect upon the approval of 3,4–methylenedioxymethamphetamine (MDMA) as a prescription drug by the United States Food and Drug Administration and the secretary of the commonwealth shall publish notice of the effective date of this act in the Massachusetts Register.